The DementAI team has made significant strides in the early detection of Alzheimer's disease by utilizing SAS Viya's advanced AI and machine learning technologies. This innovative approach allows clinicians to identify the disease up to two years earlier than traditional methods.
SAS Viya's integrated capabilities not only enhance diagnostic accuracy but also prioritize the trust and oversight essential in healthcare settings. This balance is crucial for maintaining patient confidence in AI-driven solutions.
By focusing on early detection, the DementAI initiative aims to improve patient outcomes and provide clinicians with the tools needed to intervene sooner, ultimately leading to better management of Alzheimer's disease.